Navigation Links
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
Date:3/31/2008

ce call to review financial results for the quarter and year ended December 31, 2007 and recent business developments. The call is scheduled for today, March 31, 2008, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). To participate in the live conference call, U.S. residents should dial 877-407-4018, and international callers should dial 201-689-8471. Alternatively, log on to http://www.imarx.com to access a live webcast of the call. Please connect to the Investor section of ImaRx's website several minutes prior to the start of the live conference call to ensure adequate time for any software download that may be necessary. To access the 48-hour telephone replay, U.S. residents should dial 800-660-6853, and international callers should dial 201-612-7415. The account number for the event is 3055, and the conference ID number is 279436. A replay of the call will also be available on http://www.imarx.com 14-days following the call.

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company commercializing and developing therapies for vascular disorders. The Company's commercialization efforts are currently focused on its first FDA-approved thrombolytic agent, urokinase, for the treatment of acute massive pulmonary embolism, or blood clot in the lungs. The Company's research and development efforts are focused on therapies for stroke and other vascular disorders using its proprietary MRX-801 microbubble technology.

Cautionary Statement For The Purpose Of The "Safe Harbor" Provisions Of The Private Securities Litigation Reform Act of 1995

Note: Statements made in this press release which are not historical in nature constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements include: those related to the search for strategic alternatives
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. ImaRx to Report Corporate Updates and 4Q07 Financial Results
3. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
8. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
9. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
10. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
11. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 Topical ... helping those in pain end their suffering, restoring hope ... healthcare model. This is only possible because of the ... and healing cream technology a reality. , The ... Rhinebeck, NY, by Lou Paradise (president, chief of research, ...
(Date:9/22/2014)... 22, 2014 Follow us ... natural biopolymers available in abundance in nature. These ... resources such as shells of crustaceans. The significant ... due to the high percentage of nitrogen present ... in various industries owing to its exclusive properties ...
(Date:9/22/2014)... 22, 2014 Follow us ... stay young has groomed and nurtured anti-aging products ... Growing emphasis on appearance maintenance is benefitting the ... neurotoxic protein obtained from the bacterium, Clostridium Botulinum, ... muscle relaxation. With cosmetic indications for botulinum toxin ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... Chinese Microcrystalline Cellulose Industry Report 2014" report to ... Microcrystalline Cellulose Industry Report 2014 is a professional and ... microcrystalline cellulose industry with a focus on the Chinese ... of the industry including definitions, classifications, applications and industry ...
Breaking Biology Technology:Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 4Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 5Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 6Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 2Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 3Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2
... The Albert and Mary Lasker Foundation, which for 66 ... the winners of the 2011 Lasker Awards : Franz ... basic medical research, Tu Youyou for clinical research and ... for public service. The Lasker Awards – considered among the most ...
... 2011 Mass High Tech has selected ... recipient of its 2011 All-Stars Award, one that recognizes ... economy.   Camacho will be recognized for ... the life sciences sector.  As a patent attorney, she ...
... low-intensity, pulsed ultrasound can be used to noninvasively ... rapid-response medical devices. The team that made that ... professor with the Virginia Tech Carilion Research Institute, ... approach, which may one day lead to first-line ...
Cached Biology Technology:2011 Lasker Awards Honor Medical Research Pioneers 22011 Lasker Awards Honor Medical Research Pioneers 32011 Lasker Awards Honor Medical Research Pioneers 42011 Lasker Awards Honor Medical Research Pioneers 52011 Lasker Awards Honor Medical Research Pioneers 62011 Lasker Awards Honor Medical Research Pioneers 7Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award 2Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 2Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 3
(Date:9/22/2014)... (AM), or 3D printing, has rapidly advanced to ... strong enough for structural applications. However, developing complex ... as quality standards to test the manufactured items, ... at the University of Pittsburgh,s Swanson School of ... simulation (M&S) technology and new qualification standards that ...
(Date:9/22/2014)... be much more useful in homes, if they could ... the world with cameras and lasers, which have difficulty ... hidden in clutter. A complementary way robots can "sense" ... small ultra-high frequency radio-frequency identification (UHF RFID) tags. Inexpensive ... RFID-equipped robot to search a room for the correct ...
(Date:9/22/2014)... 2,819 people have occurred in the wake of the ... Eldorado National Forest. The King Fire is burning ... American River Canyon, Silver Creek Canyon, and the Rubicon ... fire has crossed into Placer County and burned onto ... Forest. The anticipated spread is expected to be minimal ...
Breaking Biology News(10 mins):Pitt engineers receive grants to enhance additive manufacturing 2Pitt engineers receive grants to enhance additive manufacturing 3New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3
... -- Jade Holding Group, LLC dba Strax Rejuvenation, one ... wellness centers, has just announced that it is now ... and women who are interested in getting a hair ... to help. (Photo: http://photos.prnewswire.com/prnh/20130830/MN72022 ) ...
... York have discovered that very small chemical changes to dietary ... are tested for their impact on the human immune system., ... small molecules an average leaf for example, produces around ... and some are already known to have medicinal properties with ...
... receive $1.3 million over the next five years from ... Diseases (NIDDK) for research that will help better understand ... of novel treatments to reverse the disease. The ... suffer from type 2 diabetes--a number expected to double ...
Cached Biology News:Hair Transplant Offer and No-Cost Consultation are Now Available at Strax Rejuvenation 2Hair Transplant Offer and No-Cost Consultation are Now Available at Strax Rejuvenation 3Little changes -- large effects 2Type 2 diabetes study to examine role amylin plays in disease 2
...
... The FailSafe™ PCR System is the only ... first time and every time. It provides ... of the source or the property of ... FailSafe™ PCR Enzyme Mix, a unique blend ...
...
... EnVision™ G|2 Doublestain System is a ... visualization kit. The kit is intended ... simultaneous detection of two different antigens ... compatible with suitably diluted rabbit and ...
Biology Products: